Search results
Results from the WOW.Com Content Network
Currently, the lines between an EMR, a personal health record, and a patient portal are blurring. [1] For example, Intuit Health and Microsoft HealthVault describe themselves as personal health records (PHRs), but they can interface with EMRs and communicate through the Continuity of Care Record standard, displaying patient data on the Internet ...
The difference between an opioid and an opioid agonist is that opioids induce more intense effects and stay in the brain for a short amount of time. [3] Conversely, an opioid agonist induces minimal effects and stays in the brain for a long time, which prevents the opioid user from feeling the effects of natural or synthetic opioids. [3]
The Modernizing Opioid Treatment Access Act is a proposed United States congressional bill introduced in the 118th United States Congress. Introduced in response to the national opioid epidemic , the legislation would expand access to methadone , an approved medication for treating opioid use disorder (OUD).
Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid ...
If approved, the new plan would end the costliest corporate bankruptcy resulting from the U.S. opioid crisis. Purdue Pharma, Sackler families boost contribution in opioid settlement to $7.4 billion
Codeine is a nonsynthetic opioid. [32] It is a selective agonist of the μ-opioid receptor (MOR). [32] Codeine itself has relatively weak affinity for the MOR. [32] [27] Instead of acting directly on the MOR, codeine functions as a prodrug of its major active metabolites morphine and codeine-6-glucuronide, which are far more potent MOR agonists ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
According to a Cochrane review in 2013, extended-release morphine as an opioid replacement therapy for people with heroin addiction or dependence confers a possible reduction of opioid use and with fewer depressive symptoms but overall more adverse effects when compared to other forms of long-acting opioids. The length of time in treatment was ...